Alkermes plc. 4

Insider Nancy Lynn Snyderman, MD exercised 44,472 Alkermes plc (ALKS) stock options at $46.72 and sold 44,472 ordinary shares at a weighted average price of $50.348 on 2026-08-03.

On 2026-08-03, Nancy Lynn Snyderman, MD, an insider of Alkermes plc, exercised two tranches of non-qualified stock options for a total of 44,472 ordinary shares at an exercise price of $46.72 per share, and on the same date sold 44,472 ordinary shares in the market at a weighted average price of $50.348 per share, effectively executing a cashless or sell-to-cover style transaction. The option exercises added 27,948 and 16,524 ordinary shares, respectively, to her direct holdings, after which the subsequent sale of 44,472 shares reduced her direct ownership to 15,395 ordinary shares, with an additional 20,783 shares held indirectly through the Nancy Lynn Snyderman Revocable Trust, for which she is sole trustee and sole beneficiary. The gross value of the exercised shares was approximately $2.08 million based on the exercise price, while the sale proceeds were approximately $2.24 million based on the reported weighted average sale price; these options were fully vested and the transactions appear to be part of routine equity compensation monetization rather than an outright directional purchase or sale.

Filing Facts

CIK

1520262

Ticker

ALKS

Form

4

Source Type

fda

Accession

0001520262-26-000111

Alert Tier

6